Sábila para Cicatrización de heridas diabéticas
Aloe vera — 8 estudios científicos revisados
Preliminary¿Sirve Sábila para cicatrización de heridas diabéticas?
La investigación científica ha explorado el potencial de Sábila (Aloe vera) en relación con cicatrización de heridas diabéticas. Se han identificado 8 estudios relevantes que examinan esta relación.
Compuestos activos involucrados: Flavonoides, Saponinas, Terpenos, Polisacárido
Evidencia Científica
Los siguientes estudios han investigado la relación entre Sábila y cicatrización de heridas diabéticas:
Aloe vera polysaccharides facilitate diabetic wound healing by promoting macrophage M(2) polarization through inhibition of NLRP3 inflammasome activation.
BACKGROUND: Diabetic wound healing impairment poses a serious threat to patient health, underscoring the urgent need for effective therapies. Aloe polysaccharides (APs), one of the main bioactive components of Aloe vera, have been reported to exhibit diverse biological activities, including antibacterial, antioxidant, anti-obesity, and anti-tumor effects. However, their role in diabetic wound repair remains unclear, limiting its translational potential. PURPOSE: This study aims to clarify the therapeutic effect and specific mechanism of APs on diabetic wound healing. STUDY DESIGN AND METHODS:
PubMed: 41935465Aloe-emodin microemulsion gel for diabetic wounds: optimizing surfactant-polymer synergy for effective wound management.
AIM: The present study aimed to develop and optimize an Aloe-emodin-loaded microemulsion gel (AMEG) to improve topical delivery, bioavailability, and therapeutic efficacy for diabetic wound healing. MATERIALS AND METHODS: AMEG was formulated using a D-optimal mixture design, employing Capryol 90 as the oil phase, Labrasol and Tween 80 as surfactants, and Transcutol P as the co-surfactant. The optimized microemulsion was incorporated into a konjac glucomannan (KGM) gel matrix to enhance skin adherence and wound-healing potential. The formulation was characterized for droplet size, clarity, in v
PubMed: 41922302Characterization and Migration Activity of Thermoresponsive Silk Fibroin-Aloe Vera Gel in Normal and Diabetic Fibroblasts.
Diabetic wounds remain a major clinical challenge due to delayed healing caused by chronic inflammation and impaired fibroblast activity. Here, we present a thermoresponsive gel composed of chitosan (CS) and poloxamers (POL) incorporating silk fibroin (SFB) and Aloe vera gel extract (AV), developed for topical application and, for the first time, evaluated using an inflammation-induced diabetic fibroblast model. The optimized formulation exhibited rapid sol-gel transition at physiological temperature and suitable rheological properties for effective wound coverage. In vitro evaluation using hu
PubMed: 41892511Aloe vera as an herbal medicine in the treatment of metabolic syndrome: A review.
Metabolic syndrome (MS) is a highly prevalent health problem worldwide and is associated with different risk factors, including hyperglycemia, dyslipidemia, hypertension, and obesity. This condition increases the risk of developing type II diabetes mellitus and cardiovascular problems. The MS is one of the most important health concerns in industrialized countries and mainly results from a sedentary lifestyle, high levels of subjective stress, and unhealthy diets. Nowadays, the identification of appropriate health care approaches, such as herbal medicines, with fewer side effects is more favor
PubMed: 31456283The Effect of Aloe vera on the Healing of Diabetic Foot Ulcer: A Randomized, Double-blind Clinical Trial.
BACKGROUND: Diabetic foot ulcer (DFU) is a prevalent complication of diabetes that can result in severe consequences. The cost of treating DFUs is high, and there is a lack of new therapies available in developing countries. This has created a demand for complementary and alternative treatments. The objective of this study was to assess the impact of aloe vera gel on the healing process of diabetic foot ulcers. MATERIALS AND METHODS: The study was a double-blind, randomized, controlled clinical trial.
PubMed: 37670716Seguridad y Precauciones
La seguridad del uso de la Sábila (Aloe vera) es un tema complejo que depende estrictamente de la parte de la planta utilizada (gel vs. látex) y la vía de administración. En el caso de mujeres embarazadas y en periodo de lactancia, el consumo oral de la planta está contraindicado. El látex de la sábila contiene antraquinonas (como la aloína), las cuales pueden inducir contracciones uterinas y estimular la actividad del útero, lo que representa un riesgo de aborto espontáneo o parto prematuro. Asimismo, los compuestos pueden pasar a la leche materna, con el riesgo de causar efectos laxantes severos en el lactante. En niños menores de 12 años, el uso debe ser extremadamente cauteloso y preferiblemente limitado a aplicaciones tópicas sobre la piel (evitando el contacto con mucosas o ingestión), debido a que sus sistemas digestivos y metabólicos son más sensibles a las propiedades irritantes de las saponinas y antraquinonas, lo que podría provocar deshidratación por diarrea.
Perfil completo: Ver todos los usos y evidencia de Sábila →